Convergent Therapeutics

Last updated: August 12, 2024

Founder Philip Kantoff
Founder Philip Kantoff
USA | Funding: $90M (+)

Website: https://convergentrx.com

Convergent Therapeutics is a pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate cancers